![Siegfried Hekimi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Siegfried Hekimi
Corporate Officer/Principal chez McGill University
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Bert Vandal | M | 63 |
McGill University
| 18 ans |
John Edward Cleghorn | M | 82 |
McGill University
| - |
Tullio Cedraschi | M | 85 |
McGill University
| - |
Phillip Gold | M | 83 |
McGill University
| - |
Michael Churchill-smith | M | - |
McGill University
| 37 ans |
Marie-Josée Lamothe | F | 56 |
McGill University
| - |
Joe Clark | M | - |
McGill University
| - |
Mikihiro Yasuda | M | 53 |
McGill University
| 11 ans |
David Goltzman | M | - |
McGill University
| - |
Nicola Walter Palmieri | M | 89 |
McGill University
| - |
John W. Commissiong | M | 79 |
McGill University
| - |
Armen Aprikian | M | - |
McGill University
| - |
Sylvain Chemtob | M | - |
McGill University
| - |
Hugh Scott | M | - |
McGill University
| - |
Hyman M. Schipper | M | - |
McGill University
| - |
Paul Chipperton | M | - |
McGill University
| - |
Guy Laliberté | M | - |
McGill University
| - |
Hartley S. Stern | M | - |
McGill University
| - |
Nicolas Matziorinis | M | - |
McGill University
| 36 ans |
Warren J. Gross | M | - |
McGill University
| - |
Elliot Lifson | M | - |
McGill University
| - |
Jeannie L. Haggerty | M | - |
McGill University
| - |
Viviane Yargeau | M | - |
McGill University
| 20 ans |
Amit Bar-Or | M | - |
McGill University
| - |
Mark Ware | M | - |
McGill University
| 23 ans |
Jean-Francois Yale | M | - |
McGill University
| - |
Sarkis Meterissian | M | 62 |
McGill University
| - |
Michael DiGrappa | M | - |
McGill University
| - |
Danny Ritter | M | - |
McGill University
| - |
Tina Hobday | F | - |
McGill University
| - |
Alvin Shrier | M | - |
McGill University
| - |
Daniel Levitin | M | - |
McGill University
| - |
Joel Cohen | M | - |
McGill University
| - |
Pierre Matuszewski | M | - |
McGill University
| - |
Shie Mannor | M | - |
McGill University
| - |
Andrew Karaplis | M | - |
McGill University
| - |
Samuel Minzberg | M | 67 |
McGill University
| - |
Richard I. Levin | M | 75 |
McGill University
| 18 ans |
François Painchaud | M | 60 |
McGill University
| - |
Thomas Kierans | M | 81 |
McGill University
| - |
Gerald Sheff | M | - |
McGill University
| - |
Manon R. Vennat | F | - |
McGill University
| - |
Stephen Halperin | M | 74 |
McGill University
| - |
Maryse Bertrand | F | 65 |
McGill University
| 8 ans |
James Jonathan Nelson | M | 76 |
McGill University
| - |
Michael Boychuk | M | 68 |
McGill University
| - |
Perry Miele | M | 64 |
McGill University
| - |
Kenneth S. Atlas | M | - |
McGill University
| - |
Tony Falco | M | - |
McGill University
| - |
Emily Hamilton | M | - |
McGill University
| - |
Peter D. Nesgos | M | - |
McGill University
| - |
Martine Turcotte | F | 63 |
McGill University
| - |
Allan Pont | M | - |
McGill University
| - |
François Gilbert | M | - |
McGill University
| - |
Gordon C. Shore | M | - |
McGill University
| - |
Nathalie Bourque | F | - |
McGill University
| - |
Francine Gervais | M | - |
McGill University
| - |
C. Joseph Clark | M | - |
McGill University
| - |
Xin Zhao | M | 63 |
McGill University
| 31 ans |
Lawrence Hoffman | M | - |
McGill University
| - |
Ronald D. Guttmann | M | 87 |
McGill University
| - |
Samira Sakhia | F | 55 |
McGill University
| - |
Melissa Sonberg | F | 64 |
McGill University
| 10 ans |
Jan Peeters | M | 72 |
McGill University
| 25 ans |
Giovanna Santullo | F | - |
McGill University
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
M. Desbiens | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 5 ans |
Yves Fouron | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
Max Fehlmann | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 6 ans |
Pascal Puchois | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 5 ans |
Nahed K. Ahmed | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
Jean-Marie Houle | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | 4 ans |
Endri Leno | M | - |
Chronogen, Inc.
![]() Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 72 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Siegfried Hekimi
- Réseau Personnel